Cargando…
Renal replacement therapy in ADPKD patients: a 25-year survey based on the Catalan registry
BACKGROUND: Some 7-10% of patients on replacement renal therapy (RRT) are receiving it because of autosomal dominant polycystic kidney disease (ADPKD). The age at initiation of RRT is expected to increase over time. METHODS: Clinical data of 1,586 patients (7.9%) with ADPKD and 18,447 (92.1%) patien...
Autores principales: | Martínez, Víctor, Comas, Jordi, Arcos, Emma, Díaz, Joan Manel, Muray, Salomé, Cabezuelo, Juan, Ballarín, José, Ars, Elisabet, Torra, Roser |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844422/ https://www.ncbi.nlm.nih.gov/pubmed/24007508 http://dx.doi.org/10.1186/1471-2369-14-186 |
Ejemplares similares
-
Genetic kidney diseases as an underrecognized cause of chronic kidney disease: the key role of international registry reports
por: Torra, Roser, et al.
Publicado: (2021) -
Rare diseases, rare presentations: recognizing atypical inherited kidney disease phenotypes in the age of genomics
por: Ars, Elisabet, et al.
Publicado: (2017) -
Hypertension in autosomal-dominant polycystic kidney disease (ADPKD)
por: Sans-Atxer, Laia, et al.
Publicado: (2013) -
Diagnosis of autosomal dominant polycystic kidney disease using efficient PKD1 and PKD2 targeted next-generation sequencing
por: Trujillano, Daniel, et al.
Publicado: (2014) -
How genomics reclassifies diseases: the case of Alport syndrome
por: Torra, Roser, et al.
Publicado: (2020)